Allergan agrees to Actavis deal for $66 billion
November 17, 2014 at 09:24 AM EST
(Reuters) - Allergan Inc agreed to be bought by Actavis Plc for $66 billion, more than $12 billion above the current value of a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc .